Real-time enrollment status for this hidradenitis suppurativa clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 3:45 AM UTC
| NCT Number | NCT06468228 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa |
| Phase | Clinical Trial |
| Target Enrollment | 1,280 participants |
| Active Locations | 63 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | March 20, 2026 (4 weeks ago) |
As of April 17, 2026: Clinical trial NCT06468228 is currently recruiting participants. This clinical trial study for hidradenitis suppurativa is actively seeking new participants at 63 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06468228 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06468228 was last updated 4 weeks ago (March 20, 2026). HelloStudys verifies this status automatically.